- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: programmed death ligand 1 (PD-L1)
Total 52200 results
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
Lei LiRecruitingMicrosatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Maxinovel Pty., Ltd.Recruiting
-
Maxinovel Pty., Ltd.Recruiting
-
AkesoAkeso Pharmaceuticals, Inc.CompletedMelanoma | Advanced Solid TumorsChina
-
CellSight Technologies, Inc.Not yet recruitingAdvanced Non Small Cell Lung Cancer
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Stage IV | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
NYU Langone HealthEMD SeronoCompleted
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck CancerChina
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Merck Sharp & Dohme LLCGilead SciencesRecruitingCarcinoma, Non-Small-Cell LungChina, Poland, Latvia, United States, Taiwan, Australia, Turkey, Germany, Israel, Korea, Republic of, Estonia, Romania, Chile, Italy, Brazil, Greece, Philippines, Canada, Japan, Malaysia, United Kingdom, Lithuania, Thailand, Peru
-
Hutchison Medipharma LimitedRecruitingExtensive-Stage Small Cell Lung CancerChina
-
Fudan UniversityRecruiting
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingRecurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
-
Georgetown UniversityNational Cancer Institute (NCI); Mayo Clinic; Emory University; Indiana University and other collaboratorsTerminatedMetastatic Colorectal Cancer | Pancreatic Adenocarcinoma | Colorectal Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Henan Cancer HospitalRecruitingClassical Hodgkin LymphomaChina
-
National Cancer Institute (NCI)RecruitingThymic Epithelial Tumor | Thymic Cancer | Recurrent ThymomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingLocally Advanced Cervical CancerFrance
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Stand Up To Cancer; CellSight Technologies, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States
-
Peking UniversityNot yet recruitingGastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
-
BrightPath BiotherapeuticsTerminated
-
Peking Union Medical College HospitalRecruiting
-
Stanford UniversityTerminatedMerkel Cell CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Incyte CorporationRecruitingPancreatic Cancer Metastatic | Pancreatic Cancer Non-resectableUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsGermany
-
Checkpoint Therapeutics, Inc.Novotech (Australia) Pty LimitedRecruitingMelanoma | Renal Cell Carcinoma | Head and Neck Cancer | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Non Hodgkin Lymphoma | Endometrial Cancer | Carcinoma, Small Cell | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Malignant Mesothelioma, AdvancedAustralia, New Zealand, Thailand, Ukraine, Spain, Russian Federation, France, Poland, South Africa
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Hunan Cancer... and other collaboratorsRecruitingNasopharyngeal Carcinoma | De-escalation TherapyChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHepatocellular Carcinoma | Graft Rejection | Immunotherapy | Immune Checkpoint InhibitorChina
-
Merck Sharp & Dohme LLCEuropean Organisation for Research and Treatment of Cancer - EORTC; ETOPActive, not recruiting
-
Merck Sharp & Dohme LLCRecruitingSolid Tumor | Endometrial Cancer | Cutaneous Squamous Cell CarcinomaCanada, Taiwan, Italy, Australia, Malaysia, United States, Netherlands, Turkey, France, Germany
-
Bristol-Myers SquibbWithdrawnStage III or IV Melanoma
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruiting
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Hepatocellular CarcinomaUnited States, China, Italy, Japan, Korea, Republic of, Poland, Spain, Switzerland, Taiwan
-
Pharmassist LtdUniversity of AthensActive, not recruitingMelanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaGreece
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingSafety Issues | Effect Increased
-
Merck Sharp & Dohme LLCCompleted
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal NeoplasmsChina
-
Memorial Sloan Kettering Cancer CenterWang Initiative in Lung Cancer Clinical TrialsWithdrawnNon Small Cell Lung CancerUnited States
-
Beijing Friendship HospitalNot yet recruiting
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Highlight TherapeuticsTerminatedAdvanced Hepatocellular Carcinoma | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular Carcinoma | Refractory Hepatocellular CarcinomaUnited States
-
Kidney Cancer Research BureauRecruitingMetastatic Gastric Cancer | FGFR2 Amplification | PD-L1 Gene AmplificationUnited States
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRTChina
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingNon-small Cell Lung Cancer | Advanced Lung Carcinoma
-
Consorzio OncotechActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene MutationItaly